Hydrofarm raises $8.3M to wipe out $109M term loan
What's the deal? Hydrofarm Holdings Group (Nasdaq: HYFM) priced an approximately $8.3 million registered direct offering and concurrent private placement on October 27, 2026, and struck agreements to satisfy its $109 million senior secured term loan in full with equity. Chairman and chief executive officer Bill Toler, alongside other officers and directors, will buy in on the same terms as outside investors.
The details: The offering combines 1,599,400 registered shares at $0.905, plus 7,611,575 unregistered shares or pre-funded warrants and 9,210,975 common warrants exercisable at $0.78. ThinkEquityDealroom has a profile for this one. Try Dealroom → acted as sole placement agent. Hydrofarm plans to use net proceeds for general corporate purposes.
Why now? The hydroponics equipment maker is under acute balance-sheet strain. Second-quarter 2026 sales fell 40.9% year over year to $23.2 million, and the company held just $6.2 million in cash against its term loan. It had already deferred an interest payment, entered lender forbearance, and sold its Canadian peat business for $16 million.
The debt swap: To retire the loan, lenders will receive 27 million shares of Series 1 Non-Voting Convertible Preferred Stock and warrants for 27.5 million common shares at $0.78. The move eliminates a major secured obligation and releases related liens.
What could go wrong? The equity consideration carries heavy dilution. Combined, the preferred shares, lender warrants, offering shares, and common warrants create a large overhang against the current share count — and key conversions still need shareholder approval. Hydrofarm also flagged risks to its Nasdaq listing compliance.
The signal: This is a survival-oriented restructuring, not a growth raise. The deal reflects persistent oversupply and weak demand across the hydroponics industry — trading debt for equity to stay afloat, rather than any sign of a sector rebound.
Read more: minichart.com.sg
Image credit: Generated with Gemini
